MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

Search

Elanco Animal Health Inc

Gesloten

SectorGezondheidszorg

10.79 4.35

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

10.16

Max

10.79

Belangrijke statistieken

By Trading Economics

Inkomsten

-372M

-8M

Verkoop

-10M

1B

K/W

Sectorgemiddelde

15.441

63.778

EPS

0.14

Winstmarge

-0.784

Werknemers

9,000

EBITDA

-779M

8M

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+48.12% upside

Dividenden

By Dow Jones

Volgende Winsten

7 mei 2025

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-279M

5.2B

Vorige openingsprijs

6.44

Vorige sluitingsprijs

10.79

Nieuwssentiment

By Acuity

7%

93%

3 / 386 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Strong Bullish Evidence

Elanco Animal Health Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

27 jun 2024, 14:34 UTC

Belangrijke Marktbewegers

Elanco Shares Retreat Over Zenrelia Warning Label Concerns

9 jul 2024, 12:30 UTC

Acquisities, Fusies, Overnames

Merck Animal Health Completes Acquisition Of Elanco's Aqua Business >MRK

9 jul 2024, 12:29 UTC

Acquisities, Fusies, Overnames

Elanco Animal Health Sees Ending 2024 With Net Debt to Adjusted Ebitda in Mid-4x Range >ELAN

9 jul 2024, 12:28 UTC

Acquisities, Fusies, Overnames

Elanco Animal Health: $1.05B-$1.1B Net Proceeds Available for Debt Paydown in 3Q >ELAN

9 jul 2024, 12:28 UTC

Acquisities, Fusies, Overnames

Elanco Completes Sale of Aqua Business to Merck >ELAN MRK

2 mei 2024, 17:43 UTC

Winsten

Zoetis Stock Climbs on Earnings Beat, but Worries Linger Over Key Medicine -- Barrons.com

2 mei 2024, 13:06 UTC

Winsten

Zoetis Stock Climbs on Earnings Beat, but Worries Linger Over Key Medicine -- Barrons.com

Peer Vergelijking

Prijswijziging

Elanco Animal Health Inc Prognose

Koersdoel

By TipRanks

48.12% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 15.33 USD  48.12%

Hoogste 20 USD

Laagste 12 USD

Gebaseerd op 10 Wall Street-analisten die 12-maands prijsdoelen bieden voor Elanco Animal Health Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

10 ratings

7

Buy

3

Hold

0

Sell

Technische score

By Trading Central

10.53 / 10.81Steun & Weerstand

Korte Termijn

Strong Bullish Evidence

Gemiddeld Termijn

Weak Bearish Evidence

Lange Termijn

Weak Bearish Evidence

Sentiment

By Acuity

3 / 386 Rangschikking in Gezondheidszorg

Nieuwssentiment

Zeer Sterk Bearish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Elanco Animal Health Inc

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.